Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 119 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Antineoplastic Agents  [Clear All Filters]
2013
Atmatzidis, S., Chatzimavroudis G., Ananiadis A., Kapoulas S., & Atmatzidis K. (2013).  Giant GIST of the small intestine in a young man.. J Gastrointest Surg. 17(8), 1536-7.
Zarogoulidis, K., Ziogas E., Boutsikou E., Zarogoulidis P., Darwiche K., Kontakiotis T., et al. (2013).  Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.. Drug Des Devel Ther. 7, 611-7.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Kioumis I., Porpodis K., et al. (2013).  Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.. Int J Pharm. 456(2), 325-31.
Hohenforst-Schmidt, W., Zarogoulidis P., Darwiche K., Vogl T., Goldberg E. P., Huang H., et al. (2013).  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.. Drug Des Devel Ther. 7, 571-83.
Fountzilas, G., Kotoula V., Pectasides D., Kouvatseas G., Timotheadou E., Bobos M., et al. (2013).  Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.. PLoS One. 8(7), e69256.
Apalla, Z., Karteridou A., Lallas A., Tzellos T., Lefaki I., Sotiriou E., et al. (2013).  Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid.. Dermatol Surg. 39(1 Pt 1), 146-7.
Zarogoulidis, P., Yarmus L., & Zarogoulidis K. (2013).  New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.. Ther Deliv. 4(10), 1221-3.
Nicolatou-Galitis, O., Nikolaidi A., Athanassiadis I., Papadopoulou E., & Sonis S. (2013).  Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.. Oral Surg Oral Med Oral Pathol Oral Radiol. 116(2), e110-6.
Kyrgidis, A., Athanassios K., Tzellos T-G., Trigoni A., & Triaridis S. (2013).  p16 post-hoc analyses and Simpson's paradox.. Lancet Oncol. 14(11), e436.
Shetye, N. G., Mataftsi A., Maeder P., Moulin A. P., Gaillard M-C., Balmer A., et al. (2013).  Post-chemoreduction cryptic optic nerve relapse in a patient with bilateral retinoblastoma.. Br J Ophthalmol. 97(2), 233, 245-6.
Strimpakos, A., Pentheroudakis G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., et al. (2013).  The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.. Clin Colorectal Cancer. 12(4), 267-274.e2.
Bamias, A., Dafni U., Karadimou A., Timotheadou E., Aravantinos G., Psyrri A., et al. (2013).  Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).. Ann Oncol. 24(4), 1011-7.
2012
Pectasides, D., Papaxoinis G., Kotoula V., Fountzilas H., Korantzis I., Koutras A., et al. (2012).  Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.. Oncol Rep. 27(1), 216-24.
Korantzis, I., Kalogeras K. T., Papaxoinis G., Kotoula V., Koutras A., Soupos N., et al. (2012).  Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.. Anticancer Res. 32(10), 4569-80.
Kotoula, V., Krikelis D., Karavasilis V., Koletsa T., Eleftheraki A. G., Televantou D., et al. (2012).  Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).. BMC Cancer. 12, 342.
Zarogoulidis, P., Eleftheriadou E., Sapardanis I., Zarogoulidou V., Lithoxopoulou H., Kontakiotis T., et al. (2012).  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.. Invest New Drugs. 30(4), 1628-40.
Murray, S., Karavasilis V., Bobos M., Razis E., Papadopoulos S., Christodoulou C., et al. (2012).  Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer.. J Exp Clin Cancer Res. 31, 77.
Trakatelli, M., Siskou S., Proby C., Tiplica G. S., Hinrichs B., Altsitsiadis E., et al. (2012).  The patient journey: a report of skin cancer care across Europe.. Br J Dermatol. 167 Suppl 2, 43-52.
Tsachouridou, O., Christoforidou A., Metallidis S., Papaioannou M., Kollaras P., Kolokotronis A., et al. (2012).  Plasmablastic lymphoma of the oral cavity, a B cell-derived lymphoma associated with HIV infection: a case series.. Eur Arch Otorhinolaryngol. 269(6), 1713-9.
Tsolakidis, D., Papanikolaou A., Ktenidis K., & Pervana S. (2012).  Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature.. Eur J Gynaecol Oncol. 33(3), 312-5.
Raoul, J-L., Bruix J., Greten T. F., Sherman M., Mazzaferro V., Hilgard P., et al. (2012).  Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.. J Hepatol. 56(5), 1080-8.
Chelis, L., Souftas V., Amarantidis K., Xenidis N., Chamalidou E., Dimopoulos P., et al. (2012).  Reversible posterior leukoencephalopathy syndrome induced by pazopanib.. BMC Cancer. 12, 489.
Pectasides, D., Papaxoinis G., Kalogeras K. T., Eleftheraki A. G., Xanthakis I., Makatsoris T., et al. (2012).  XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.. BMC Cancer. 12, 271.
2011
Kanellos, D., Pramateftakis M. G., Mantzoros I., Zacharakis E., Raptis D., Despoudi K., et al. (2011).  The effects of the intraperitoneal administration of oxaliplatin and 5-FU on the healing of colonic anastomoses: an experimental study.. Tech Coloproctol. 15 Suppl 1, S111-5.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές